HAEMOPHILIA A WITH INHIBITORS
Clinical trials for HAEMOPHILIA A WITH INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A WITH INHIBITORS trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A WITH INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot Mim8 shows promise in preventing bleeds for hemophilia a patients
Disease control CompletedThis study looked at how safe it is for people with hemophilia A to switch from their current medicine (emicizumab) to a new one called Mim8. Mim8 is injected under the skin weekly, every two weeks, or monthly to help prevent bleeding episodes. The study involved 61 adults and te…
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 26, 2026 08:08 UTC
-
New shot could slash bleeding episodes for hemophilia patients
Disease control CompletedThis study tested a new medicine called Mim8 in 281 adults and teens with hemophilia A, including those with inhibitors. Mim8 helps replace missing clotting factor to prevent bleeding episodes. Participants received injections once a week or once a month. The study lasted up to 2…
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 22, 2026 14:02 UTC